As Alzheimer’s news goes, this tidbit is optimistic: An experimental drug to treat the memory-loss disease is safer than scientists originally expected. Researchers were concerned that bapineuzumab, a drug therapy being tested in mild to moderate Alzheimer’s patients, carried the side effect of ...
Related News:-
J&J Will Seek FDA Approval by 2013 for Alzheimer’s Drug
Johnson & Johnson (JNJ) will seek U.S. regulatory approval of the experimental Alzheimer’s treatment bapineuzumab in 2012 or 2013, sticking with efforts to treat a ...
Alzheimer's drug market to more than triple to $13.3 billion in ...
The emergence of new agents that have the potential to affect disease progression, the Alzheimer's disease drug market will more than triple, from $4.3 billion in 2009 to $13.3 ...
Alzheimer's drug market to hit $5.5 billion by 2009, study says ...
Toronto-based Millennium Research Group predicts the Alzheimer's disease drug market in the United States, Europe and Japan will grow by 15 percent annually for the next five years ...
Safety Concerns Reported for Alzheimer's Drug Razadyne (Previously ...
Trials have indicated that people taking the Alzheimer's disease drug Razadyne, previously known as Reminyl (galantamine) have a much higher death rate than those taking ...
Alzheimer's disease - Wikipedia, the free encyclopedia
Alzheimer's disease (AD), also called Alzheimer disease, senile dementia of the Alzheimer type, primary degenerative dementia of the Alzheimer's type, or simply Alzheimer's, is the ...
Alzheimer's drug news and articles
Alzheimer's drug clinical trial halted after nine deaths 5/10/2010 - Elan Corp. and Transition Pharmaceuticals have called a premature halt on trials on the two highest doses of ...
Researchers funded by Merck & Co/Johnson & Johnson identify ...
Scientists have discovered a small molecule that helps human cells get rid of the misfolded, disfigured proteins implicated in Alzheimer’s disease and other neurodegenerative ...
Drug Trials Test Bold Plan to Slow Alzheimer’s
“What are we waiting for?” she asks. About 10 minutes later, she asks again. Then she asks again. She is waiting to enter a new type of Alzheimer’s drug study ...
Alzheimer's Association
Alzheimer's Association - Alzheimer's Association ... AAIC Press Releases More> AAIC Web site. Falls May Indicate Earliest Stages of Alzheimer's and Need for Further Evaluation
No comments:
Post a Comment